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Introduction {#sec1}
============

As adaptor molecules for the translational machinery, tRNAs transport their cognate amino acids to cytoplasmic ribosomal complexes, translating the genetic information of mRNA into nascent polypeptide chains ([@bib60]). In eukaryotic cells, tRNAs are transcribed by RNA polymerase III within the nucleus. tRNA transcripts undergo a series of post-transcriptional processing steps that are required to yield fully mature and functional tRNAs ([@bib28]). As a critical post-transcriptional maturation step, the enzyme tRNA nucleotidyl transferase catalyzes the addition of the ubiquitous CCA nucleotides to the 3′ end of tRNA molecules prior to their export from the nucleus ([@bib68]).

The dogma of unidirectional movement held that tRNAs are produced inside the nucleus and exported into the cytoplasm to function in protein translation ([@bib60]). This tenet of unidirectional transport was initially challenged by the observation that, in yeast, tRNAs are spliced on the surface of mitochondria, but spliced tRNAs were detected inside the nucleus ([@bib75]). This led to the provocative hypothesis that tRNAs might be exported from the nucleus to the cytoplasm, spliced on mitochondria, and then re-imported into the nucleus, which was later confirmed ([@bib57], [@bib63]). Independently, we were investigating cellular factors driving HIV-1 nuclear import. Using biochemical fractionation approaches, we isolated a fraction able to support HIV-1 nuclear import into human cells *in vitro*. Purified to near homogeneity, the fraction contained tRNAs mostly with defective 3′ CCA ends, and we demonstrated that such defective tRNAs were efficiently imported into the nucleus in an energy-dependent manner ([@bib76]), suggesting that HIV-1 co-opts the physiological import of certain tRNA species for its own nuclear import. tRNA nuclear import has since been reported in rat hepatoma cells ([@bib58]), Chinese hamster ovary cells ([@bib4]), and human 293T cells ([@bib42], [@bib67]). This pathway is now called "tRNA retrograde transport" ([@bib28]).

In S. *cerevisiae*, tRNA retrograde transport is constitutive, whereas re-export of imported tRNAs is regulated by nutrient availability ([@bib8], [@bib29], [@bib43]). Therefore, this pathway is likely to regulate protein translation by modulating the pool of tRNAs available in the cytoplasm in response to nutrients ([@bib11]). tRNA retrograde transport has also been shown to be a quality control mechanism for tRNA modification and for defective or immature tRNAs ([@bib35], [@bib46]).

Constitutive tRNA import in S. *cerevisiae* agrees with the notion that, in yeast, tRNA splicing takes place in the cytoplasm and that re-import into the nucleus of spliced tRNAs is required for certain modifications ([@bib46]). In human cells, however, tRNA splicing and maturation take place only inside the nucleus ([@bib48], [@bib60]). Furthermore, digitonin-permeabilized human cells appear to preferentially import *in-vitro*-synthesized tRNAs lacking a complete 3′ CCA end, whereas intact yeast cells import both mature and 3′-end-truncated endogenous tRNAs with similar efficiency ([@bib63], [@bib76]). Therefore, important differences in how tRNA retrograde transport is regulated in human and yeast cells may exist, which would illuminate new aspects of tRNA biology.

In the present study, we systematically investigated the regulation of retrograde tRNA transport in different human cells. We used a combination of specific tRNA fluorescent *in situ* hybridization (tFISH) to quantitatively characterize tRNA retrograde transport and next-generation sequencing to analyze the global movement of tRNAs. Our results identify tRNA retrograde transport as a component of the cellular defense mechanism against oxidative stress ([@bib61]).

Results {#sec2}
=======

Oxidative Stress Induces tRNA Nuclear Accumulation in Human Cells {#sec2.1}
-----------------------------------------------------------------

To investigate the regulation of tRNA retrograde transport in human cells, we exposed HeLa, normal human dermal fibroblasts from neonatal foreskin (neo-NHDF), and primary unstimulated CD3^+^ T cells to a variety of conditions known to induce stress ([Figure 1](#fig1){ref-type="fig"}). We monitored tRNA subcellular localization by tFISH ([@bib57], [@bib58], [@bib63]) using a digoxigenin-labeled oligonucleotide complementary to human tRNA^Lys^, an abundant species tested previously in the same assay ([@bib58]). An oligonucleotide probe complementary to tRNA^Lys^ from the bacteria *A. laidlawii* and another oligonucleotide specific for the U5 small nuclear RNA (U5 snRNA) ([@bib22]) were used as controls. Under physiological conditions, tRNA^Lys^ was mainly detected in the cytoplasm, whereas U5 snRNA was detected in the nucleus only. The background fluorescence signal was detected with a probe against tRNA^Lys^ from *A. laidlawii* (data not shown).Figure 1Oxidative Stress, MMS, and Puromycin Induce tRNA Retrograde Transport in Human CellsA tFISH assay was carried out with a probe specific for tRNA^Lys^ to survey conditions that induce tRNA retrograde transport. Each condition was tested at different time points and with different concentrations of the specified compound. Shown here are H~2~O~2~ (5 mM for 2 h); MMS (10 mM for 2 h); puromycin (3 mM for 8 min); Glc−, glucose deprivation (24 h); IFNα (1.25 × 10^4^ U/mL for 24 h); and TNF-α (1 ng/mL for 2 h). Ctrl, no treatment. Scale bars, 20 μm for HeLa and Neo-NHDF images and 10 μm for CD3+ T cells. Arrowheads point to the intranuclear signal. Representative images of at least three independent experiments are shown.See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

Each condition was tested using different incubation times and different concentrations of the stressors ([Table S1](#mmc1){ref-type="supplementary-material"}). Oxidative stress is known to affect tRNA modification, expression, and cleavage ([@bib30]) and to repress global protein translation ([@bib61]). Therefore, we tested the effect of hydrogen peroxide (H~2~O~2~), a reactive oxygen species that perturbs protein folding and activates the endoplasmic reticulum (ER) unfolded protein response (UPR) ([@bib26], [@bib55]). A hallmark of the UPR is phosphorylation at serine 51 of the α subunit of eukaryotic translation initiation factor 2 (eIF2α), which represses global translational initiation ([@bib24]). We confirmed that H~2~O~2~ induced eIF2α phosphorylation under our experimental conditions ([Figure S1](#mmc1){ref-type="supplementary-material"}A). When tRNA localization was examined by tFISH, we observed a marked increase in nuclear fluorescence intensity in samples treated with H~2~O~2~. This effect was robust across the three cell types ([Figure 1](#fig1){ref-type="fig"}). Treatment with methylmethane sulfonate (MMS), a nucleic acid-alkylating agent that causes DNA damage and perturbs tRNA modification ([@bib5], [@bib9]), induced tRNA accumulation in the nucleus of HeLa and primary human T cells but not into neo-NHDF cells ([Figure 1](#fig1){ref-type="fig"}). Premature termination of protein synthesis with puromycin has been reported previously to induce nuclear accumulation of *in-vitro*-synthesized tRNAs upon transfection in human 293T cells ([@bib4]). We found that puromycin induced accumulation of endogenous tRNA^Lys^ within the nucleus of HeLa and T cells, but this was not detectable in neo-NHDF cells ([Figure 1](#fig1){ref-type="fig"}; see also [Figure S2](#mmc1){ref-type="supplementary-material"} for quantification).

Glucose deprivation is known to induce retrograde tRNA accumulation in S. *cerevisiae* ([@bib31], [@bib57], [@bib58], [@bib64], [@bib69]); hence, we incubated human cells in the absence of glucose. Glucose deprivation is known to result in de-phosphorylation of 4E-BP1 and reduced protein translation ([@bib56]); thus, we examined phosphorylation of 4E-BP1 in our experimental conditions. Although we could confirm the loss of phosphorylated 4E-BP1 ([Figure S1](#mmc1){ref-type="supplementary-material"}B), we could not detect accumulation of tRNA^Lys^ within the nucleus after glucose starvation ([Figure 1](#fig1){ref-type="fig"}; [Table S1](#mmc1){ref-type="supplementary-material"}).

Type I interferon (IFN) inhibits protein synthesis via the protein kinase R (PKR) pathway ([@bib52]), and tumor necrosis factor alpha (TNF-α) induces broad changes in protein translation that are linked to ER stress, although the mechanisms are poorly defined ([@bib66], [@bib77]). Therefore, we treated cells with recombinant IFNα or TNF-α. qRT-PCR showed upregulation of the IFN-stimulated gene *IFIT-2* ([@bib38]) and the TNF-α-induced *IL-6* and *I-CAM* genes ([@bib2]) ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D), but tFISH did not show nuclear accumulation of tRNA^Lys^ ([Figure 1](#fig1){ref-type="fig"}). We also tested osmotic shock and low or high pH but did not detect nuclear tRNA accumulation ([Table S1](#mmc1){ref-type="supplementary-material"}). No tRNA^Lys^ nuclear accumulation was detected after heat shock ([Table S1](#mmc1){ref-type="supplementary-material"}), which is consistent with the observation that this kind of stress only affects tRNA^Met^ ([@bib67]). Based on these results, we concluded that oxidative stress was the most consistent inducer of tRNA nuclear accumulation in human cells tested in our experimental settings. Genotoxic stress and translational inhibition induced a cell type-specific response, whereas other stress conditions did not seem to induce significant tRNA nuclear accumulation, at least under the conditions tested ([Table S1](#mmc1){ref-type="supplementary-material"}).

Next we examined the kinetics of tRNA nuclear accumulation after cells were exposed to H~2~O~2~, MMS, or puromycin. The tFISH signal in the nucleus and cytosol was quantified, and the nuclear:cytosolic fluorescence ratio (N/C) was calculated at each different time point ([Figure S2](#mmc1){ref-type="supplementary-material"}). Accurate quantification of the signal in primary T cells was not possible because of the small size of their cytoplasm. In HeLa cells, tRNA nuclear accumulation was apparent 1 h after exposure to H~2~O~2~, reaching a peak at 2 h ([Figure S2](#mmc1){ref-type="supplementary-material"}). Similar results were obtained in neo-NHDF and primary T cells ([Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}A). A similar response was detected in HeLa cells treated with MMS ([Figure S2](#mmc1){ref-type="supplementary-material"}). Puromycin has been shown previously to change the intracellular distribution of exogenous transfected tRNAs within 30 min ([@bib4]); hence, we performed a shorter time course by tFISH, which showed that this drug indeed triggered a faster response than H~2~O~2~ in HeLa cells, reaching a peak at 7.5 min ([Figure S2](#mmc1){ref-type="supplementary-material"}).

Dose responses were obtained by titrating H~2~O~2~ and quantifying the tFISH signal as above. Maximal efficacy was reached at 5 mM in HeLa cells, 2.5 mM in neo-NHDF cells ([Figure 2](#fig2){ref-type="fig"}), and 0.3 mM in primary T cells ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Thus, although the response to H~2~O~2~ is consistent across different cell types, its threshold is cell-type-dependent, consistent with the notion that cancer cells have a greater tolerance for oxidative stress than normal cells ([@bib66]).Figure 2The Effect of H~2~O~2~ Is Concentration-Dependent(A) Representative confocal microscopy images showing the changes in nuclear tFISH signal upon addition of H~2~O~2~ at the indicated concentrations. Scale bar, 20 μm.(B) ImageJ software was used to quantify the fluorescent signal in the nucleus (N) and cytoplasm (C) and calculate the N/C ratio. Cells were counted from at least 5 randomly chosen images. Each dot corresponds to one cell. Red lines indicate the mean value. Graphs show data from one representative experiment of at least two independent experiments. One-way ANOVA (Dunnett's multiple comparisons test) was used to calculate statistical significance between different groups. ^∗^p = 0.05, ^∗∗^p \< 0.05, ^∗∗∗∗^p \< 0.0001.See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

tRNA Nuclear Accumulation Requires Import of Existing tRNAs and Is Reversible {#sec2.2}
-----------------------------------------------------------------------------

tRNA nuclear accumulation triggered by oxidative stress might depend on the nuclear import of pre-existing cytoplasmic tRNAs or on a nuclear export block of newly synthesized tRNAs. To distinguish between these two possibilities, we pre-treated cells for 2 h with actinomycin D (ActD) before adding H~2~O~2~ and then examined the samples by tFISH. ActD is a potent and global inhibitor of *de novo* RNA synthesis, including tRNAs ([@bib58]). Hence, if tRNA nuclear accumulation was mainly due to an export block of newly synthesized tRNAs, then one should expect a lower nuclear signal upon treatment with ActD. Conversely, if tRNA nuclear accumulation was mainly due to import of pre-existing cytoplasmic tRNAs, then one should expect no difference. In cells pre-treated with ActD, the level of tRNA nuclear accumulation was either unaffected or higher than in untreated cells ([Figure 3](#fig3){ref-type="fig"}A). Furthermore, ActD reduced the cytoplasmic signal in a time-dependent way so that the N/C ratio was higher in ActD-treated than in non-ActD-treated cells ([Figures 3](#fig3){ref-type="fig"}A and 3B). This suggested that tRNAs were lost from the cytoplasm, presumably because they were imported into the nucleus without being replaced by the export of newly synthesized tRNAs in ActD-treated samples. These results demonstrated that the tFISH signal originates from nuclear import of pre-existing tRNAs. Repression of *de novo* RNA synthesis by ActD was confirmed by qRT-PCR to measure the mRNA levels of *PDX*, *RANBP1*, *TNPO1*, and *MAT1* relative to glyceraldehyde 3-phosphate dehydrogenase (*GAPDH*), a transcript shown previously to be stable under conditions of oxidative stress ([@bib37]; [Figure 3](#fig3){ref-type="fig"}C). Of note, co-staining of the ER in cells treated with H~2~O~2~ and ActD revealed loss of the tFISH signal that co-localized with the ER signal ([Figure S4](#mmc1){ref-type="supplementary-material"}A), suggesting that tRNAs were preferentially imported from the ER into the nucleus.Figure 3Pre-existing tRNAs Are Imported into the Nucleus upon Exposure to H~2~O~2~(A) ActD was added to the cells at the same time as H~2~O~2~ (5 mM) (2 h total incubation time with ActD) or 2 h before addition of H~2~O~2~ (4 h total incubation time with ActD). Two h after exposure to H~2~O~2~, samples were analyzed by tFISH and confocal microscopy to detect tRNA^Lys^. Scale bars, 20 μm.(B) The N/C ratio was calculated as described in the legend for [Figure 1](#fig1){ref-type="fig"}. One-way ANOVA (Dunnett's multiple comparisons test) was used to calculate statistical significance; ^∗∗∗∗^p \< 0.0001.(C) Inhibition of *de novo* RNA synthesis under these experimental conditions was confirmed by qRT-PCR to measure the mRNA levels of the indicated genes. Expression levels are relative to *GAPDH* mRNA levels.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

To determine whether nuclear accumulation of tRNAs induced by oxidative stress is reversible, HeLa cells were treated for 2 h with H~2~O~2~; then, H~2~O~2~ was removed, and cells were analyzed by tFISH at different time points ([Figures S4](#mmc1){ref-type="supplementary-material"}B--S4D). We found that removal of H~2~O~2~ resulted in rapid loss of the nuclear signal, which returned to control levels between 10 and 30 min. Hence, oxidative stress induces fully reversible nuclear accumulation of tRNAs. These results also demonstrate that treatment with H~2~O~2~ did not cause any irreversible damage to the cells, which maintained their ability to export or degrade nuclear tRNAs following recovery from stress. Indeed, the vast majority of cells treated with H~2~O~2~ for 2 h were alive ([Figure S4](#mmc1){ref-type="supplementary-material"}E).

Retrograde tRNA Transport Induced by Oxidative Stress Is Selective {#sec2.3}
------------------------------------------------------------------

Next we sought to understand whether oxidative stress induced retrograde transport of all tRNAs or of specific subsets. To obtain a global view of tRNA retrograde transport, we performed strand-specific deep RNA sequencing using thermostable group II intron reverse transcriptase (TGIRT), a recently developed method that allows high-throughput sequencing of small structured RNAs, including tRNAs ([@bib45], [@bib49]). HeLa cells were treated for 2 h with H~2~O~2~ in the presence of ActD, harvested, and fractionated into nuclear and cytosolic fractions. The quality of fractionation was confirmed by western blot using antibodies specific for *GAPDH*, protein disulfide isomerase (PDI), and lamin-B1 (lamin) as markers for the cytosol, the ER, and the nucleus, respectively ([Figure 4](#fig4){ref-type="fig"}A). Between 6 and 12 million reads were obtained for each sample. Total reads were mapped to the ENSEMBLE non-coding RNA (ncRNA) set that includes more than 300 unique tRNA gene sequences obtained from the Genomic tRNA Database (gtRNAdb) ([@bib40]). Initial optimization for the preparation of the sequencing library revealed that treatment with demethylase reduced the overall yield and tended to degrade the tRNA 3′ end, which was critical for our analyses, presumably because of difficult-to-remove contamination with RNase. Because we did not treat the samples with demethylase, tRNA modifications might have prematurely blocked reverse transcription, introducing mapping artifacts ([@bib12], [@bib78]). To examine this issue, we assessed coverage of each single position in a tRNA covariance model using more than 1,000 tRNA alignments from RFAM (<http://rfam.xfam.org/>) and checked against known RNA modifications ([@bib6]). The overall coverage was good, although it was lower at the 5′ end between nucleotides 1 and 30, presumably because of stalling of the enzyme during the reverse transcription step. This higher rate of "stopping" at the 5′ end has been observed previously ([@bib12]). However, this lower 5′ end coverage did not prevent mapping of the tRNAs ([Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}A).Figure 4Oxidative Stress Induces Changes in the Overall Composition of the Cytosolic and Nuclear tRNA PoolsHeLa cells were treated with ActD in the presence or absence of 5 mM H~2~O~2~ for 2 h. Cells were fractionated into a nuclear and cytosolic fraction, RNA extracted from each fraction, and next-generation sequencing (TGIRT) of small RNAs was performed.(A) Western blot of nuclear and cytosolic fractions with antibodies detecting marker proteins for the nucleus and cytoplasm. *GAPDH*, glyceraldehyde 3-phosphate dehydrogenase; PDI, protein disulfide isomerase; lamin, lamin-B1.(B) Total RNA reads were mapped to 323 unique tRNA genes. All reads mapping to the same tRNA species were counted and combined, and their relative distribution was calculated. tRNAs were clustered according to their relative abundance in the nucleus.(C) Heatmap showing the Log~2~ fold change (Log~2~FC) of tRNA-specific reads in nuclear or cytoplasmic fractions of cells treated with H~2~O~2~ relative to untreated cells. tRNA-specific reads were mapped to the 3′ end of the tRNAs and sorted for intact tRNAs (with a full 3′ CCA end) and defective tRNAs (with an incomplete 3′ end). A threshold base mean of more than 20 reads was applied across all samples.(D) Cumulative abundance of intact or 3′ end-truncated tRNAs in the cytosolic and nuclear fractions upon treatment with H~2~O~2.~ Sequencing reads were mapped to the 3′ end of the tRNAs at single-nucleotide resolution for the first 13 nucleotides. The relative amount of each tRNA species is shown for each missing nucleotide at the 3′ end.See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"} and [Tables S2](#mmc2){ref-type="supplementary-material"}, [S3](#mmc3){ref-type="supplementary-material"}, [S4](#mmc4){ref-type="supplementary-material"}, and [S5](#mmc5){ref-type="supplementary-material"}.

The majority of mapped reads (62%--83%) belonged to small non-coding RNAs, and up to 30% of these could be mapped to tRNAs ([Figure S6](#mmc1){ref-type="supplementary-material"}A). However, only ≅5% of the total reads could be mapped in our third biological replicate; therefore, this replicate was not included in subsequent analyses. Analysis of the ten most abundant reads revealed clear enrichment of nucleus- and nucleolus-specific small ncRNAs in the nuclear fraction and of cytosol-specific small RNAs, including several mitochondrion-encoded tRNAs, in the cytoplasmic fraction, further confirming the high quality of the fractionation ([Figure S6](#mmc1){ref-type="supplementary-material"}B).

To assess whether the overall composition of the tRNA pool within the cytosol and nucleus changed upon treatment with H~2~O~2~, all normalized unique reads were counted and clustered according to tRNA amino acid usage ([Figure 4](#fig4){ref-type="fig"}B; [Figure S6](#mmc1){ref-type="supplementary-material"}C) and isoacceptors ([Table S2](#mmc2){ref-type="supplementary-material"}). Their relative distribution inside the nucleus and the cytoplasm was calculated for each replicate: tRNA^Lys^, tRNA^Gly^, tRNA^Glu^, and tRNA^Asp^ were the most abundant species, covering more than 50% of all tRNA reads. This result matches a recently published study that used TGIRT to quantify tRNA isoacceptor abundance in the Universal Human Reference RNA ([@bib45]). In our samples, the least abundant tRNAs were tRNA^Phe^, tRNA^Tyr^, tRNA^Cys^, and tRNA^Trp^. Under oxidative stress conditions, the proportion of tRNAs for selenocysteine, alanine, serine, threonine, and isoleucine in the nucleus was higher relative to glycine and aspartic acid. This effect was observed in each biological replicate ([Figure 4](#fig4){ref-type="fig"}B; [Table S2](#mmc2){ref-type="supplementary-material"}). The relative proportion of tRNA^Lys^ increased in the nucleus upon oxidative stress; however, this was observed in one biological replicate only ([Figure 4](#fig4){ref-type="fig"}B).

These results suggested that tRNA retrograde transport might be selective for certain tRNA species. Thus, we sought to address the question of selectivity. Furthermore, we previously reported that, in digitonin-permeabilized human cells, *in-vitro*-synthesized tRNAs lacking a complete 3′ CCA end were preferentially imported into the nucleus relative to tRNAs with a full 3′ CCA end ([@bib76]). However, it was not known whether this applies to endogenous tRNAs as well. Thus, we sought to understand the type of tRNAs (intact or truncated at the 3′ end) that undergo retrograde transport under oxidative stress.

To this end, we examined the distribution of each intact (tRNA with a mature 3′ CCA end) and defective (tRNAs missing at least one nucleotide at their 3′ end) gene in the nucleus and cytoplasm upon treatment with H~2~O~2~. We mapped all reads to intact and 3′-truncated tRNA transcript versions and calculated the Log~2~ fold change (Log~2~FC). For greater stringency, we counted only tRNA genes with a sequencing depth of at least 20 reads in the cytosolic control samples, which resulted in a pool of 208 unique tRNA genes suitable for further analyses ([Table S3](#mmc3){ref-type="supplementary-material"}). This analysis revealed a cluster of truncated tRNAs enriched and another cluster of intact tRNAs reduced in the nuclear fractions ([Figure 4](#fig4){ref-type="fig"}C; [Table S4](#mmc4){ref-type="supplementary-material"}), with 58 tRNA genes reaching statistical significance (p \< 0.05) and 19 tRNA genes reaching an adjusted p value (adjp) of less than 0.05 ([Table S3](#mmc3){ref-type="supplementary-material"}). Changes in the cytosol were modest, and no tRNA gene reached statistical significance ([Figure 4](#fig4){ref-type="fig"}C; [Table S3](#mmc3){ref-type="supplementary-material"}). To further improve confidence in the results, we focused on tRNAs that showed a consistent positive or negative Log~2~FC \>0.75 in both biological replicates. Using this cutoff, in the nuclear fraction we found one intact tRNA (tRNA^Ala^) and 24 defective tRNAs, including tRNA^Sec^, tRNA^Ala^, tRNA^Val^, tRNA^Asn^, tRNA^Ser^, tRNA^Lys^, and tRNA^Ile^, that were increased by oxidative stress, whereas, in the cytosolic fraction, we found two intact (tRNA^Ala^ and tRNA^Ile^) and three defective tRNAs, which were increased ([Figure S7](#mmc1){ref-type="supplementary-material"}; [Table S5](#mmc5){ref-type="supplementary-material"}). tRNA^Sec\ (TCA)^ (cca_chr19-tr09), one of the most highly changed tRNA following treatment with H~2~O~2~, was reduced by an average of 2.7-fold in the cytoplasm and increased by an average of 8.6-fold in the nucleus ([Tables S2](#mmc2){ref-type="supplementary-material"} and [S4](#mmc4){ref-type="supplementary-material"}).

To further examine the nature of these defective tRNAs, sequencing reads were mapped to the 3′ end of the tRNAs at single-nucleotide resolution, and the relative distribution of each tRNA in the nucleus and cytosol was calculated for control and H~2~O~2~-treated samples ([Figure 4](#fig4){ref-type="fig"}D). In the cytosolic control, approximately 50% of reads mapped to intact tRNAs, whereas the remaining portion lacked between 1 to 6 nt at their 3′ end. Oxidative stress had a marginal effect on the proportion of reads mapping to defective tRNAs. In the nucleus, however, only 30% of reads mapped to intact tRNAs in H~2~O~2~-treated cells compared with 60% of reads in control cells. Many defective tRNAs in the nucleus lacked between 5 and 8 nt at their 3′ end ([Figure 4](#fig4){ref-type="fig"}D). Overall, these analyses suggested that nuclear accumulation involved predominantly certain tRNA species with truncated 3′ ends, although it cannot be excluded that some 3′ end shortening also occurred in the nucleus following oxidative stress.

To confirm the selectivity of the tRNA retrograde transport induced by oxidative stress, we examined, by tFISH, four tRNAs that showed robust nuclear accumulation according to RNA sequencing (RNA-seq) (tRNA^Glu^~,~ tRNA^Ala^, tRNA^Lys^, and tRNA^Sec^) and two that did not (tRNA^Gly^ and tRNA^Arg^). In agreement with the RNA-seq results, tRNA^Ala^, tRNA^Sec^, tRNA^Glu^, and tRNA^Lys^ showed significant nuclear accumulation whereas tRNA^Gly^ and tRNA^Arg^ did not ([Figure 5](#fig5){ref-type="fig"}). This result could not be explained by the relative abundance of the tRNAs because, for example, tRNA^Gly^ was 28 times more abundant than tRNA^Ala^, but tRNA^Ala^ clearly accumulated into the nuclei and tRNA^Gly^ did not ([Figure 5](#fig5){ref-type="fig"}). We also sought to confirm by other means the presence of truncated tRNAs in the nucleus of cells treated with H~2~O~2~. To this end, cells were treated for 2 h with H~2~O~2~, fractionated into nuclear and cytoplasmic extracts and examined by northern blot ([Figure 5](#fig5){ref-type="fig"}). The results confirmed the presence of bands of smaller size relative to their corresponding intact tRNAs for tRNA^Glu^, tRNA^Lys^, tRNA^Ala^, and, possibly, tRNA^Sec^, whereas the results were inconclusive for tRNA^Arg^ because of the insufficient sensitivity of the northern blot for this particular tRNA ([Figure 5](#fig5){ref-type="fig"}). Importantly, the smaller bands were detected in the nuclear fractions of cells treated with H~2~O~2~ but not in untreated cells.Figure 5tRNA Retrograde Transport in Human Cells Is SelectiveTop: cells were exposed to 5 mM H~2~O~2~ for 2 h without ActD and analyzed by tFISH with the indicated tRNA probe. Representative confocal microscopy images of the tFISH assay are shown. Scale bars, 10 μm. Center: the N/C ratio was calculated as described in the legend for [Figure 1](#fig1){ref-type="fig"}. The graphs show data from one representative experiment of at least two. One-way ANOVA (Dunnett's multiple comparisons test) was used to calculate statistical significance; ^∗∗∗∗^p \< 0.0001. Bottom: cells were fractionated into nuclear (N) and cytosolic (C) fractions. Total RNA was extracted from each fraction and analyzed by northern blot using the same tRNA-specific probes employed for the tFISH. Each image is representative of at least two independent experimentsSee also [Figure S7](#mmc1){ref-type="supplementary-material"}.

tRNA Retrograde Transport Is Regulated by *REDD1* and *mTOR* {#sec2.4}
------------------------------------------------------------

Oxidative stress affects pathways that ultimately result in inhibition of global protein translation and induction of specific stress response proteins, which protect cells from deleterious damage ([@bib21], [@bib24], [@bib26]). To better understand the effect of H~2~O~2~ in our cellular model, we sought to profile the expression of marker genes of mammalian target of rapamycin (mTOR), one of the key pathways that affect protein translation during oxidative stress ([@bib54]). Cells were treated for 2 h with H~2~O~2~, and RNA was extracted and reverse-transcribed. Changes in gene expression were quantified by real-time qPCR ([Table S6](#mmc6){ref-type="supplementary-material"}). Notably, the only significantly upregulated gene in the network was *REDD1* (also called *DDTI4*) ([Figure 6](#fig6){ref-type="fig"}A), which senses oxidative stress and inhibits mTOR through the *TSC1* and *TSC2* complex ([@bib7]). Conversely, the most significantly downregulated genes were *PTEN*, *PDK1*, *PIK3C2*, and *PIK3CD (*[Figure 6](#fig6){ref-type="fig"}A), which stimulate mTOR via AKT activation. Thus, the transcriptional changes converged to reduce mTOR activity, and this was confirmed by the lower levels of phosphorylated S6 and 4EBP, two key targets of mTOR, in H~2~O~2~-treated cells relative to control cells ([Figure 6](#fig6){ref-type="fig"}B).Figure 6*REDD1/DDIT4* Regulates tRNA Retrograde Transport(A) HeLa cells were exposed to 5 mM H~2~O~2~ for 2 h, and changes in RNA expression were analyzed using a pre-coated 96-well qPCR assay with probes specific for the mTOR signaling pathway. Significant up and downregulated genes (FC \>1.5, p ≤ 0.05) are indicated in red and green, respectively.(B) Inhibition of the mTOR pathway was confirmed by western blot to detect phosphorylation of the translation inhibitor 4EBP and the ribosomal protein S6 (Ser235/236).(C) *REDD1* knockout MEFs (REDD^−/−^) showing reduced tRNA retrograde transport when treated with 3 mM H~2~O~2~ compared with wild-type cells (REDD^+/+^). Arrows point to cells with a positive nuclear signal. Scale bar, 10 μm.(D) *REDD1* protein expression analysis by western Blot for *REDD*^+/+^ and *REDD*^−/−^ cells.(E) The N/C ratio was calculated as described in the legend for [Figure 1](#fig1){ref-type="fig"}. Unpaired two-tailed Student's t test was used to calculate statistical significance.(F) Cells were incubated for 4 h with the hypoxia mimetic agent desferrioxamine (DFO, 5 mM), and tRNA nuclear accumulation was detected by tFISH and quantified by ImageJ. The graphs show data from one representative experiment of three.(G) Stabilization of HIF-1 was detected by western blot in parallel experiments, and actin was used as a loading control.See also [Table S6](#mmc6){ref-type="supplementary-material"}.

*REDD1* acts upstream of *mTOR*; it is an important sensor of cellular stress whose expression is rapidly upregulated to promote cell survival ([@bib7], [@bib17]). We therefore hypothesized that *REDD1* is essential for tRNA retrograde transport. To test this hypothesis, we obtained wild-type and *REDD1*^*−/−*^ mouse embryonic fibroblasts (MEFs) ([@bib7]; [Figures 6](#fig6){ref-type="fig"}C and 6D), exposed them to H~2~O~2~ for 2 h, and performed tRNA FISH. We found a significantly lower nuclear signal (p \< 0.05) in *REDD1*^*−/−*^ MEFs relative to wild-type cells ([Figures 6](#fig6){ref-type="fig"}C and 6E), confirming the role of this gene in tRNA retrograde transport. *REDD1* was initially described as a hypoxia-induced target gene of HIF-1 ([@bib59]), which prompted us to examine whether HIF-1 was stabilized by H~2~O~2~ under our experimental conditions and, therefore, could induce *REDD1* expression. However, western blot analysis did not show stabilization of HIF-1 under H~2~O~2~. Conversely, desferrioxamine, a well-known HIF-1 stabilizer ([@bib72]), induced HIF-1 stabilization but did not recapitulate H~2~O~2~-induced tRNA retrograde transport ([Figures 6](#fig6){ref-type="fig"}F and 6G). These results indicate that tRNA retrograde transport is disconnected from HIF-1.

Beside HIF-1, the transcription of *REDD1* is also regulated by *ATF4*, which is a transcription factor induced by the UPR stress signaling pathway ([@bib70]). A hallmark of the UPR is eIF2α phosphorylation ([@bib24]), and we have already observed that tRNA retrograde transport induced by oxidative stress occurs in parallel with eIF2α phosphorylation ([Figure S1](#mmc1){ref-type="supplementary-material"}). This suggested that activation of the UPR pathway might also regulate tRNA retrograde transport by linking oxidative stress to the upregulation of *REDD1.* To further investigate this potential link, we inhibited each of the three kinases that can independently phosphorylate eIF2α in the UPR pathway: *GNC2* (called *EIF2AK4* in *Homo sapiens*), *PKR*, and *PERK* ([@bib25]). Small interfering RNA (siRNA)-mediated depletion of *GNC2* ([Figures 7](#fig7){ref-type="fig"}A and 7B) or a selective small-molecule PKR inhibitor ([@bib33]; [Figure 7](#fig7){ref-type="fig"}C) did not affect eIF2α phosphorylation induced by H~2~O~2~ or had any effect on tRNA retrograde transport. However, when we treated cells with a selective inhibitor of PERK ([@bib3]), we observed reduced eIF2α phosphorylation and a dose-dependent inhibition of tRNA nuclear accumulation ([Figure 7](#fig7){ref-type="fig"}D). Altogether, these results suggest that tRNA retrograde transport induced by oxidative stress depends on crosstalk between *PERK* and *mTOR* that is orchestrated by *REDD1*.Figure 7*PERK* Regulates tRNA Retrograde Transport(A) Top: cells treated with siRNA targeting *GNC2* (*EIF2AK4*) or with scrambled siRNA were incubated with 5 mM H~2~O~2~ for 2 h, and tRNA nuclear accumulation was detected by tFISH and quantified by ImageJ. Bottom: western blot showing S51 phosphorylation of eIF2α in the presence or absence of H~2~O~2~ in mock and *GCN2/EIF2AK4*-depleted cells.(B) qRT-PCR to detect *EIF2AK4* mRNA in cells transfected with the targeting or scrambled siRNAs.(C) Top: cells were treated with 5 mM H~2~O~2~ for 2 h in the presence or absence of the imidazole-oxindole PKR inhibitor C16 (PKRi, 300 nM), and tRNA nuclear accumulation was detected by tFISH and quantified by ImageJ. Bottom: S51phosphorylation of eIF2α was detected by western blot, and lamin was used as a loading control.(D) Top: cells were incubated with 5 mM H~2~O~2~ for 2 h in the presence of different concentration of the PERK inhibitor GSK 2606414 (GSK), and tRNA nuclear accumulation was detected by tFISH and quantified by ImageJ. Bottom: S51 phosphorylation of eIF2α was detected by western blot, and lamin was used as a loading control.(E) Schematic summary of the pathways regulating tRNA retrograde transport.Statistical significance was calculated by unpaired two-tailed Student's t test (A and C) or by one-way ANOVA (Dunnett's multiple comparisons test) (D).

Discussion {#sec3}
==========

Our study shows that tRNA retrograde transport is activated by H~2~O~2~ in a concentration- and time-dependent manner and that this pathway is selective for certain tRNA species, mainly involves tRNAs with a defective 3′ end, and is connected to the integrated stress response.

Our results based on RNA-seq suggest that tRNA retrograde transport is selective for certain tRNA genes, mainly with a truncated 3′ end. Caution is required when interpreting the RNA-seq results because only a relatively small proportion of tRNAs reached statistical significance. The large number of tRNA genes analyzed and the few biological replicates it was possible to sequence reduced the overall power of the analysis. Nonetheless, a consistent pattern emerged from the two biological replicates. and the specific nucleo-cytoplasmic distribution of several tRNAs was confirmed by tFISH and northern blotting, suggesting that the tRNA-seq revealed a genuine trend. Currently we do not know the mechanisms of this selectivity; however, we note that, in yeast, several tRNA export factors have been described recently that show remarkable selectivity for certain tRNAs ([@bib10]). Presumably, tRNA retrograde transport in human cells may also depend on several importers, each having a specific substrate.

Our data also indicate that, in human cells, tRNA retrograde transport involves mainly truncated tRNAs lacking a complete 3′ end, which is consistent with our previous findings in digitonin-permeabilized cells ([@bib76]). Although we do not know how these defective tRNAs are generated, in yeast, plant, and mammalian cells, oxidative stress has been shown to induce rapid cleavage of tRNAs to produce tRNA halves (called tiRNAs \[tRNA stress-induced fragments\]) ([@bib65], [@bib74]). Transfection of these tiRNAs repressed global protein translation in an eIF2α phosphorylation-independent way, suggesting that tiRNAs are a component of a separate stress response pathway ([@bib32], [@bib74]). Furthermore, in *Tetrahymena*, small tRNA fragments are found associated with Piwi proteins upon starvation ([@bib13]). The endoribonuclease angiogenin generates tiRNAs ([@bib20], [@bib32], [@bib74]) and cleaves the terminal A residue of the 3′ end CCA tail under oxidative stress ([@bib15]); hence, it may generate at least part of the truncated tRNAs we observed. However, the heterogeneity of the tRNA 3′ ends also suggests that a 3′ to 5′ exonuclease might be involved.

Several conditions triggered tRNA retrograde transport in human cells (namely, puromycin, MMS, and H~2~O~2~), but only H~2~O~2~ activated the pathway in all cell types tested, indicating that this response may be universal. Of note, the H~2~O~2~ concentration required to activate retrograde transport was higher in HeLa cells relative to neo-NHDF and primary T cells, which is consistent with the previously reported lower sensitivity of cancer cells to oxidative stress ([@bib14]). In yeast, tRNA nuclear accumulation is observed under conditions of glucose starvation ([@bib8], [@bib29], [@bib69]). Human cells do not seem to trigger tRNA retrograde transport in response to this particular stress. However, based on our results, we cannot conclude that, in human cells, tRNA retrograde transport is insensitive to nutrient deprivation because we only detected tRNA^Lys^ by tFISH, and a wider survey of different tRNAs in different cell types and nutrient deprivation conditions would be required. Instead, our results point to the intriguing possibility that tRNA retrograde transport might be a cell type-specific response.

H~2~O~2~ is a reactive oxygen species that mediates intracellular signaling by promoting reversible oxidation of cysteine residues within proteins ([@bib55], [@bib71]). When cells are exposed to high concentrations of H~2~O~2~, cysteine oxidation becomes irreversible, causing permanent protein damage ([@bib55]). Accumulation of damaged proteins activates the UPR, leading to phosphorylation of eIF2α, which reduces translational initiation and activates the ATF4-dependent transcriptional program ([@bib24]). Our results indicate that tRNA retrograde transport depends on the integrated stress response pathway and involves PERK-mediated phosphorylation of eIF2α and transcriptional upregulation of *REDD1*, leading to mTOR inhibition of S6K and 4EBP ([@bib1], [@bib7]). Of note, reduced phosphorylation of S6K and 4EBP alone was not sufficient to trigger tRNA^Lys^ nuclear accumulation (for example, upon glucose deprivation), suggesting that tRNA retrograde transport requires concomitant UPR activation. Activation of these pathways results in inhibition of global protein translation and concomitant induction of specific stress response proteins, which maintain cellular homeostasis and promote cell survival for a period of time until the specific insult is removed ([@bib36], [@bib47], [@bib61]). Therefore, we propose that, in human cells, tRNA retrograde transport may be part of the integrated stress response to protect cells from damage caused by reactive oxygen species. This possibility is consistent with the rapid induction of tRNA nuclear accumulation during treatment with H~2~O~2~, its rapid reversibility, and its link to the UPR via *PERK* and phosphorylation of eIF2α. This idea provides a framework to explain the selectivity of the pathway because sequestration of specific tRNAs into the nucleus might conceivably contribute to the re-shaping of protein translation that takes place during oxidative stress.

In support of this notion, oxidative stress induced significant nuclear accumulation of both intact and truncated tRNA^SeC^. Seleno-cysteine (SeC) incorporation competes with the translation termination reaction, instead favoring translation of selenoproteins required to maintain homeostatic redox levels in cells ([@bib19]). It has been shown that the SeC-decoding complex, containing tRNA^SeC^, is assembled onto specific mRNAs in the nucleus ([@bib16]); therefore, tRNA^SeC^ retrograde transport may promote synthesis of selenoproteins and protect cells from oxidative damage. Alternatively, accumulation of truncated tRNA^Sec^ might contribute to the lowering of available tRNA^Sec^ initiated by Brf2, a redox sensor that regulates tRNA^Sec^ transcription in complex with transcription factor II B (TFIIB) ([@bib23]).

The observed induction of tRNA retrograde transport by MMS and puromycin also suggests that this pathway might protect human cells from stress. In yeast cells, certain tRNA modifications are important to ensure efficient translation of genes coding for DNA damage response proteins ([@bib5]). Indeed, tRNA modification defects have been shown to make yeast cells more susceptible to MMS-induced cell death, establishing a link between DNA damage and tRNA availability ([@bib5]). Puromycin, which acts as a non-functional mimic of aminoacyl tRNA, causes premature termination of translation, accumulation of aborted and improperly folded polypeptides, and activation of the UPR ([@bib27], [@bib44]). Therefore, our results support a unifying hypothesis ([Figure 7](#fig7){ref-type="fig"}E) whereby the selective tRNA nuclear accumulation we described might be part of a response that favors translation of certain stress-related genes while reducing global translation to protect cells from damage. It will be interesting to understand how tRNA retrograde transport integrates with other tRNA-regulatory pathways that affect tRNA stability and function in response to stress ([@bib51]). We note that stress-induced nuclear accumulation of cytoplasmic tRNAs has been recently observed in human cells using micro-injection techniques ([@bib18]). Our results underscore the importance of small RNAs in protecting cells from oxidative stress, a phenomenon conserved from bacteria to humans ([@bib62]).

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rabbit Antibody against *GAPDH*SigmaCat\# G9545; RRID: [AB_796208](nif-antibody:AB_796208){#interref85}Rabbit Antibody against lamin B1Life TechnologiesCat\# PA5-19468; RRID: [AB_10985414](nif-antibody:AB_10985414){#interref90}Rabbit Antibody against PDICell Signaling TechnologyCat\# mAb3501; RRID: ABRabbit Antibody against REDD1/DDIT4Novus BiologicalsCat\# NBP1-77321SS; RRID: [AB_11036185](nif-antibody:AB_11036185){#interref95}Rabbit Antibody against Phospho-eIF2 alphaSigmaCat\# SAB4504388Rabbit Antibody against 4EBP1Bethyl LaboratoriesCat\# A300-501; RRID: [AB_2277825](nif-antibody:AB_2277825){#interref100}Rabbit Antibody against HIF-1AbcamCat\# Ab51608; RRID: [AB_880418](nif-antibody:AB_880418){#interref105}Mouse mAb against S6 Ribosomal ProteinCell Signaling TechnologyCat\# 2317; RRID: [AB_2238583](nif-antibody:AB_2238583){#interref110}Rabbit Antibody against Phospho-S6 Ribosomal Protein (Ser235/236)Cell Signaling TechnologyCat\# 4858S; RRID: [AB_916156](nif-antibody:AB_916156){#interref115}Rabbit Antibody against ActinSigmaCat\# A2066; RRIB: [AB_476693](nif-antibody:AB_476693){#interref120}Rabbit Antibody against Na/K ATPaseSanta CruzCat\# SC58626; RRIB: [AB_781529](nif-antibody:AB_781529){#interref125}DIG specific FAB fragments (Fluorescein)RocheCat\# 11207741910; RRID: [AB_514498](nif-antibody:AB_514498){#interref130}Goat anti-rabbit antibody (HRP)DakoCat\# P0448; RRID: [AB_2617138](nif-antibody:AB_2617138){#interref135}Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbedAbcamCat\# Ab216773Goat anti mouseDakoCat\# P0447; RIID: [AB_2617137](nif-antibody:AB_2617137){#interref140}Digoxigenin Antibody (9H27L19)Thermo FisherCat\# 700772; RIID: [AB_1024571](nif-antibody:AB_1024571){#interref145}**Biological Samples**T cells, peripheral bloodhealthy volunteersN/A**Chemicals, Peptides, and Recombinant Proteins**Recombinant IFNαThermo FisherCat\# PHC4014Recombinant TNFαThermo FisherCat\# PHC3015Actinomycin DSigmaCat\# A1410Ficoll-Hypaque PlusGE HealthcareCat\# GE17-1440-02Imidazolo-oxindole PKR inhibitor C16SigmaCat\# I9785DesferrioxamineSigmaCat\# D9533EIF2AK4 (ID 440275) Trilencer-27 Human siRNAOrigeneCat\# SR318498GSK2606414MerckCat\# 516535ER Tracker™ RedThermo FisherCat\# E34250deionized FormamideSigmaCat\# F9037DextranSigmaCat\# D8906Hering Sperm DNAInvitrogenCat\#15634017ProLong Gold Antifade Mountant with DAPIMolecular ProbesCat\# P36931Nuclei Ez Prep kitSigmaCat\# NUC101TRI ReagentSigmaCat\# T9424Agencurt AMPure XP beadsBeckmanCat\# A63880**Critical Commercial Assays**TACS Annexin V-FITC Apoptosis Detection KitR&DCat\# 4830-250-KPan T cell isolation kitMiltenyi BiotecCat\# 130-096-535High-Capacity cDNA Reverse Transcription KitApplied BioscienceCat\# 4368814QuantiTect SYBR Green RT-PCR KitQIAGENCat\# 204243PureLink® miRNA Isolation KitAmbionCat\# K157001TGIRT Template-Switching RNA-seq KitInGexCat \#TGIRTKit255′DNA Adenylation KitNEBCat\# E2610SThermostable 5′ AppDNA/RNA LigaseNEBCat\# M0319SPhusion High Fidality PCR Master MixLife TechnologiesCat\# F-531SNextSeq® 500/550 Mid Output Kit v2 (150 cycles)IlluminaCat\# FC-404-2001mTOR SAB target list H96 qPCR setBioRadN/AUnfolded protein response SAB target list qPCR setBioRadN/A**Deposited Data**TGRIT sequencing dataBioProject NCBIsubmission ID: SUB2812477, BioProject NCBI: PRJNA391929**Experimental Models: Cell Lines**Neo-NHDFs (neonatal Normal Human Dermal Fibroblasts)Gift from Kim MidwoodN/AHeLaGift from Clare JollyN/A**Oligonucleotides**Please see [Table S7](#mmc7){ref-type="supplementary-material"}**Software and Algorithms**cutadapt v1.11<https://cutadapt.readthedocs.io/>[@bib41]hisat2 v2.0.4<https://ccb.jhu.edu/software/hisat2/index.shtml>[@bib34]R<https://www.r-project.org/>[@bib50]DESeq2<https://bioconductor.org/packages/release/bioc/html/DESeq2.html>[@bib39]gplots package<https://cran.r-project.org/web/packages/gplots/gplots.pdf>N/AR library ggplots2<https://cran.r-project.org/web/packages/ggplot2/index.html>N/AGraphPad Prism 7.01<https://www.graphpad.com/scientific-software/prism/>N/AImageJ 1.49<https://imagej.nih.gov/ij/>N/A**Other**GtRNAdb 2.0<http://gtrnadb.ucsc.edu/>[@bib40]Ensembl ncRNA compilation (GRCh37/75)<http://ftp.ensembl.org/pub/release-75/fasta/homo_sapiens/dna/>N/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Ariberto Fassati (<a.fassati@ucl.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

Neo-NHDFs (neonatal Normal Human Dermal Fibroblasts) (male) and HeLa cells (female) were cultured in Dulbecco's Modified Eagle Medium (DMEM) (GIBCO) supplemented with 10% FCS (Fetal Calf Serum, Labtech), 100 units/ml penicillin and 100 μg/ml streptomycin at 37°C, 5.0% CO~2~. For primary human T cell isolation, peripheral blood was obtained from healthy volunteers (one male and one female). All participants donating blood for this study gave written informed consent. Ethical approval was given by the South East Coast Research Ethics Committee under the REC reference number: 11/LO/0421 and IRAS project number: 43993. Mononuclear cells (PBMC) were isolated from fresh heparinised blood by density centrifugation using Ficoll-Hypaque Plus (GE Healthcare). CD3+ T cells were subsequently isolated from PBMC using magnetic bead isolation (Pan T cell isolation kit; Miltenyi Biotec) as per the manufacturer's instructions.

Method Details {#sec4.4}
--------------

### Induction of cellular stress {#sec4.4.1}

T cells were used 2 hours after isolation, HeLa cells and neo-NHDFs were plated at 70 - 80% confluence and 16 to 24 hours later media was changed to fresh media containing H~2~O~2~ at the indicated concentrations, or IFNα (1000 U/ml), or TNFα (10ng/ml) or glucose-free media. For heat shock, cells were incubated in a humidified incubator at 42°C for up to 1 hour. The pH of DMEM media was adjusted with 0.1% v/v from 1M HCl stock or 0.1% v/v from 1M NaOH stock. At the indicated time post-treatment, cells were washed once in phosphate buffered saline (PBS) and processed for tFISH or fractionation. To monitor viability, cells were stained for annexin and PI using the TACS Annexin V-FITC Apoptosis Detection Kit (R&D systems) following the manufacturer's instructions and analyzed by flow cytometry.

### Knockdown of EIF2AK4 {#sec4.5.7}

For transient knockdown of mRNA encoding EIF2AK4, cells were transfected with Trilencer-27 Human siRNA using Oligofectamin accordingly to the manufacturer's instructions. Briefly, for a 6-well plate transfection format, 10 μL transfection reagent and 20 μL Optimem Medium were pre-mixed. Subsequently, 161 μL Optimem and 3 μL of each siRNA oligo were added. After 20 min incubation at room temperature, 800 μL of Optimem was added and cells were transfected with 1ml transfection mixture. Four hours post-transfection, 1 mL DMEM supplemented with 20% FCS (Fetal Calf Serum, Labtech), 100 units/ml penicillin and 100 μg/ml streptomycin was added. 48 hours post-transfection, cells were split into either 6-well plates or 12-well plates for RNA extraction and tFISH analysis, respectively. Experiments were performed 72 h post-transfection.

### Fluorescence *in situ* hybridization {#sec4.5.1}

The Fluorescence *in situ* hybridization method was adapted from [@bib53]. Briefly, the day before the experiment, cells were plated into 12-well plates containing glass coverslips (VWR), which were coated with 0.0025% poly-L-lysine (Sigma-Aldrich) for experiments with neo-NHDFs. Following exposure to the indicated condition, cells were washed with PBS and subsequently fixed with freshly prepared 4% Paraformaldehyde in PBS at 25°C for 50 minutes. The reaction was quenched with 100 mM Glycine in PBS. For ER detection, cells were incubated with ER Tracker™ Red (Molecular Probes) following the manufacturer's instructions. Subsequently, cells were permeabilized with ice-cold acetone at −20°C for 3 minutes and washed three times with PBS. Coverslips were incubated for 10 minutes in pre-hybridization buffer (4x SSC, 3% BSA and 50% deionized Formamide \[Sigma\]) at 25°C. Hybridization was performed overnight at 37°C in 4x SSC, 0.2% BSA, 50% deionized Formamide, 10% Dextran (Sigma), 160 μg/ml Hering Sperm DNA (Invitrogen) and 0.7 ng/μl DIG-labeled oligonucleotides. After hybridization, cells were washed sequentially in 4x, 2x and 0,5x SSC and 50% deionized Formamide. For antibody detection of Dig labeled probes, cells were blocked with 3% BSA, 2xSSC and 0.1% Triton-100 for 2 hours at 25°C. Subsequently, DIG-labeled probes were detected with DIG specific FAB fragments **(**Roche) conjugated to Fluorescein. Samples were washed 4 times in 2x SSC and 0.1% Triton. Coverslips were mounted on microscopic slides with ProLong Gold Antifade Mountant with DAPI (Molecular Probes).

### Confocal Microscopy {#sec4.5.2}

Confocal images were acquired at the Confocal Imaging Unit (UCL Department of Cell and Developmental Biology). Single stack images were acquired on a Leica TCS SPE inverted Microscope using a 40x or 63x objective with a resolution of 1024x1024 pixels under sequentially imaging settings. DAPI and Fluorescein fluorescence emission were detected with 405nm and 488nm lasers respectively using the manufactured emission wavelength setting for DAPI and Alexa Fluor 488. Settings were adjusted for each experiment accordingly to the quality of stain but retained for all samples within the same experiment. Images were processed using LAS-X software and analyzed using ImageJ software package. Fluorescence intensities were determined after automated segregation of nuclear and cytosolic area using DAPI as nuclear stain (ImageJ macro kindly provided by Janos Kriston-Vizi, UCL).

### Cell fractionation, Northern and western blotting {#sec4.5.3}

Cells were grown in 10cm tissue culture plates and fractionated using the Nuclei Ez Prep kit (Sigma) following the manufacturer's instructions. Aliquots of 10% volume were used for western blotting and the RNA was extracted from the remaining cell lysate or fractionated lysates using Trizol. For Northern blot, 10-15 μg of purified RNA were loaded onto a 12% polyacrylamide denaturing gel containing 8M Urea in 1xTBE. Following PAGE, RNA was transferred to a positively charged nylon membrane (GE Healthcare) and crosslinked to the membrane using a conventional UV trans-illuminator. Membrane was pre-hybridized for 30 minutes at 37°C with 5xSSC, 0.1% N-Lauroyslsacrosine and 0.02% SDS, 1% Blocking reagent (Roche). Subsequently, the membrane was incubated overnight at 37°C in pre-hybridization buffer containing 5 nM heat denatured DIG-labeled probes ([@bib73]). The membrane was washed 4 times for 10 minutes each in 2xSSC and 0.1% SDS. For detection of DIG-labeled probes, the membrane was briefly washed in washing buffer (0.1M Maleic Acid, 0.15M NaCl, pH 7,5 and 0.3% Tween, pH7.5) and blocked with 0.1M Maleic Acid, 0.15M NaCl, 1% Blocking Reagent (Roche) at room temperature. Primary anti-DIG antibody (700772, Life Technology) and HRP-conjugated goat anti-rabbit antibody were diluted in 0.1M Maleic Acid, 0.15M NaCl and subsequently incubated with the membrane for 1 hour at room temperature then the membrane was washed 2 times for 15 minutes each with washing buffer. Detection was with ECL Prime Western Blotting Detection Reagent (GE Healtcare Life Science) and Hyperfilm ECL (GE Healtcare Life Science). For western blot, 1/50 of total lysates volume was loaded onto a 10% SDS-PAGE and transferred to an Immobilon-P PVDF membrane (Millipore) followed by incubation with primary and HRP-conjugated secondary antibodies and ECL detection. Inhibition of *de novo* RNA transcription by ActD was validated by quantitative PCR. 1 μg total RNA was reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) following the manufacturer's instructions. cDNAs were quantified on a Eppendorf Masterplex thermocycler using QuantiTect SYBR Green RT-PCR Kit (QIAGEN). Primer sequences are detailed in the [Key Resources Table](#sec4.1){ref-type="sec"}. Ct values were normalized to the housekeeping gene *GAPDH*.

### RNA and Sequencing Library preparation {#sec4.5.4}

For NextSeq RNA sequencing, small RNAs were enriched using the PureLink® miRNA Isolation Kit (Ambion™). The RNA library preparation was adapted from [@bib45] and [@bib49]. Briefly, 2 μg of small-size RNA (\< 200 nt) were deacylated with 0.1 mM TrisHCl pH = 9 at 37°C for 30 min in the presence of RNasin Ribonuclease Inhibitor (Promega). Potential 3′ phosphates were removed by incubation at 37°C for 45 minutes using T4 Polynucleotide Kinase (Promega). RNA was purified using Chloroform extraction and EtOH precipitation. RNA libraries were generated from 100ng treated small RNA using TGIRT™- III Enzyme (InGex, USA) using the manufacturer's protocol for the total RNA-seq method. Sequencing libraries were amplified for 15 cycles using Phusion High-Fidelity PCR Master Mix and purified using 1.3-1.4xAgentcourt AMPure XP beads. The quality of the RNA libraries was analyzed using Qubit System and TapeStation. Libraries were sequenced on an Illumina NextSeq 550 Instrument at the UCL Pathogen Genomics Unit (London).

### NextSeq RNA sequencing and analysis {#sec4.5.5}

Primer were clipped from raw read data using cutadapt v1.11 ([@bib41]). The sequences of the complete set of human tRNA genes were downloaded from GtRNAdb ([@bib40]) and pseudogenes were removed. This set was merged with the Ensembl ncRNA compilation (GRCh37/75). Clipped reads were mapped to this comprehensive set of ncRNAs including human tRNAs and all other ncRNAs using hisat2 v2.0.4 ([@bib34]). Uniquely mapped reads were counted for every gene, and differentially expressed genes were analyzed using R ([@bib50]) and DESeq2 ([@bib39]). Clustering of intact and defective tRNA were calculated with the R function heatmap.2 of the gplots package. Figures were created using the R library ggplots2 and GraphPad Prism 7.

### PCR assay for mTOR and UPR {#sec4.5.6}

HeLa cells were seeded in 6-well plates and grown overnight to 70% confluency. Next day the media was replaced and cells were treated with 5 mM H~2~O~2~ for 2.15 hours. Cells were washed with PBS and RNA was extracted using Trizol. One μg of total RNA was reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) following the manufacturer's instructions. Expression profiling was performed according to the manufacturer's instructions using PrimePCR collection assays for the mTOR signaling (SAB Target List) H96 and Unfolded protein response (SAB Target List) H96 from BioRad. Ct values have been normalized against *TBP*, *GAPDH* and *HPRT1*. The experiment has been performed using three biological replicates. Data were analyzed using the PrimerPCR Analyis software from Bio-Rad (V1.0.030.1023).

Quantification and Statistical Analysis {#sec4.6}
---------------------------------------

### Quantificaion of nuclear:cytosolic fluorescence ratio {#sec4.6.1}

Segregation of cytosolic and nuclear fluorescence signal were done on ImgageJ using subsequently following Macros (kindly provided by Janos Kriston-Vizi, UCL) and manually corrected. Approximately 100 cells were counted from at least 5 randomly chosen images per condition. Briefly, images were manually corrected for background and cells were separated using the freehand line tool of ImageJ. The DAPI staining was used to determine the area of the nucleus. For HeLa, T cells and Jurkat cells the nuclear and cytosolic segregation macros were applied and the mean fluorescence intensity calculated for the cytosolic (C) and nuclear (N) areas. tRNA subcellular localization is represented by the nuclear/cytoplasmic (N/C) ratio. For NHDF cells, nuclear (Nuc) and total cell (Cyt) raw fluorescence intensities (RID) were manually determined. The corresponding N/C ratio was calculated for each cell using the following equation:$$N/C\  = \frac{\frac{RID_{Nuc.}\ }{Area_{Nuc.}}}{\frac{\left( {RID_{Cyt.} - \ RID_{Nuc.}} \right)}{\left( {Area_{Cyt.} - \ Area_{Nuc.}} \right)\ }}$$The calculated N/C ratios were subsequently plotted using the GraphPad Prism software program (GraphPad Software, Inc.).

#### Nuclear segregation macro {#sec4.6.1.1}

run("Properties...," "channels=1 slices=1 frames=1 unit=pixel pixel_width=1 pixel_height=1 voxel_depth=1.0000000");imagetitle = getTitle();rename("bin");run("Split Channels");run("Properties...," "channels=1 slices=1 frames=1 unit=pixel pixel_width=1 pixel_height=1 voxel_depth=1");selectWindow("bin (blue)");setAutoThreshold("Otsu dark");setOption("BlackBackground," true);run("Convert to Mask");run("Dilate");run("Fill Holes");run("Set Measurements...," "mean standard median display redirect=\[bin (green)\] decimal=2");run("ROI Manager...");run("Analyze Particles...," "size=500-Infinity display exclude clear add");Cytosolic segregation macro:run("Set Measurements...," "mean standard median display redirect=\[bin (green)\] decimal=2");setForegroundColor(0,0,0);// roiManager("Deselect");// roiManager("Delete");selectWindow("bin (green)");run("Duplicate...," "title=\[bin (green)\_blank\]");selectWindow("bin (blue)");run("Create Selection");selectWindow("bin (green)\_blank");run("Restore Selection");run("Fill," "slice");run("Select None");setAutoThreshold("Otsu dark");run("Convert to Mask");run("Median...," "radius=2");run("BinaryDilateNoMerge8 ", "iterations=2 white"); // Install BinaryDilateNoMerge8\_.class from <http://www.mecourse.com/landinig/software/software.html>selectWindow("bin (blue)");run("Select None");run("Duplicate...," "title=\[NucRing\]");run("BinaryDilateNoMerge8 ", "iterations=2 white");selectWindow("bin (blue)");run("Create Selection");selectWindow("NucRing");run("Restore Selection");run("Fill," "slice");run("Select None");imageCalculator("Add create," "bin (green)\_blank,""NucRing");selectWindow("Result of bin (green)\_blank");run("Analyze Particles...," "size=500-Infinity display exclude clear add");

#### Statistical analysis {#sec4.6.1.2}

One-way Anova (Dunnett's multiple comparisons test) was used to calculate statistical significance ^∗^p = 0.05; ^∗∗^p \< 0.05; ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001 between the means of multiple independent groups. Unpaired two-tailed Student's t test was performed to compare results from H~2~O~2~ induced sample to control as indicated in the figure legends. A p value \< 0.05 was deemed statistically significant.

Data and Software Availability {#sec4.7}
------------------------------

The TGRIT sequencing data have been deposited at BioProject NCBI, submission ID: SUB2812477, BioProject NCBI: PRJNA391929.
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